Cargando…

A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy

BACKGROUND: Traditional CTV-PTV margin recipes are not generally applicable in the situation of stereotactic ablative radiotherapy (SABR) treatments of multiple target volumes with a single isocentre. In this work, we present a novel geometric method of margin derivation based on CBCT-derived anatom...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyons, Ciara A., King, Raymond B., Osman, Sarah O.S., McMahon, Stephen J., O’Sullivan, Joe M., Hounsell, Alan R., Jain, Suneil, McGarry, Conor K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543558/
https://www.ncbi.nlm.nih.gov/pubmed/28778178
http://dx.doi.org/10.1186/s13014-017-0859-z
_version_ 1783255167641059328
author Lyons, Ciara A.
King, Raymond B.
Osman, Sarah O.S.
McMahon, Stephen J.
O’Sullivan, Joe M.
Hounsell, Alan R.
Jain, Suneil
McGarry, Conor K.
author_facet Lyons, Ciara A.
King, Raymond B.
Osman, Sarah O.S.
McMahon, Stephen J.
O’Sullivan, Joe M.
Hounsell, Alan R.
Jain, Suneil
McGarry, Conor K.
author_sort Lyons, Ciara A.
collection PubMed
description BACKGROUND: Traditional CTV-PTV margin recipes are not generally applicable in the situation of stereotactic ablative radiotherapy (SABR) treatments of multiple target volumes with a single isocentre. In this work, we present a novel geometric method of margin derivation based on CBCT-derived anatomical data. METHODS: Twenty patients with high-risk localized prostate cancer were selected for retrospective review. Individual volumes of interest (prostate, prostate and seminal vesicles and pelvic lymph nodes) were delineated on five representative CBCTs and registered to the planning CT using two registration protocols: bone match or prostate-based soft tissue match. Margins were incrementally expanded around composite CTV structures until 95% overlap was achieved. RESULTS: CTV-PTV margins of 5.2, 6.5 and 7.6 mm were required for prostate, prostate and seminal vesicles and pelvic lymph nodes respectively using a prostate matching protocol. For the prostate and seminal vesicle structures, margins calculated using our method displayed good agreement with a conventional margin recipe (within ±1.0 mm). CONCLUSIONS: We have presented an alternative method of CTV-PTV margin derivation that is applicable to SABR treatments with more than one isocentric target. These results have informed an institutional trial of prostate and pelvic nodal SABR in men with high-risk localized prostate cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-017-0859-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5543558
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55435582017-08-07 A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy Lyons, Ciara A. King, Raymond B. Osman, Sarah O.S. McMahon, Stephen J. O’Sullivan, Joe M. Hounsell, Alan R. Jain, Suneil McGarry, Conor K. Radiat Oncol Research BACKGROUND: Traditional CTV-PTV margin recipes are not generally applicable in the situation of stereotactic ablative radiotherapy (SABR) treatments of multiple target volumes with a single isocentre. In this work, we present a novel geometric method of margin derivation based on CBCT-derived anatomical data. METHODS: Twenty patients with high-risk localized prostate cancer were selected for retrospective review. Individual volumes of interest (prostate, prostate and seminal vesicles and pelvic lymph nodes) were delineated on five representative CBCTs and registered to the planning CT using two registration protocols: bone match or prostate-based soft tissue match. Margins were incrementally expanded around composite CTV structures until 95% overlap was achieved. RESULTS: CTV-PTV margins of 5.2, 6.5 and 7.6 mm were required for prostate, prostate and seminal vesicles and pelvic lymph nodes respectively using a prostate matching protocol. For the prostate and seminal vesicle structures, margins calculated using our method displayed good agreement with a conventional margin recipe (within ±1.0 mm). CONCLUSIONS: We have presented an alternative method of CTV-PTV margin derivation that is applicable to SABR treatments with more than one isocentric target. These results have informed an institutional trial of prostate and pelvic nodal SABR in men with high-risk localized prostate cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-017-0859-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-08-04 /pmc/articles/PMC5543558/ /pubmed/28778178 http://dx.doi.org/10.1186/s13014-017-0859-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lyons, Ciara A.
King, Raymond B.
Osman, Sarah O.S.
McMahon, Stephen J.
O’Sullivan, Joe M.
Hounsell, Alan R.
Jain, Suneil
McGarry, Conor K.
A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy
title A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy
title_full A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy
title_fullStr A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy
title_full_unstemmed A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy
title_short A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy
title_sort novel cbct-based method for derivation of ctv-ptv margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543558/
https://www.ncbi.nlm.nih.gov/pubmed/28778178
http://dx.doi.org/10.1186/s13014-017-0859-z
work_keys_str_mv AT lyonsciaraa anovelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy
AT kingraymondb anovelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy
AT osmansarahos anovelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy
AT mcmahonstephenj anovelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy
AT osullivanjoem anovelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy
AT hounsellalanr anovelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy
AT jainsuneil anovelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy
AT mcgarryconork anovelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy
AT lyonsciaraa novelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy
AT kingraymondb novelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy
AT osmansarahos novelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy
AT mcmahonstephenj novelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy
AT osullivanjoem novelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy
AT hounsellalanr novelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy
AT jainsuneil novelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy
AT mcgarryconork novelcbctbasedmethodforderivationofctvptvmarginsforprostateandpelviclymphnodestreatedwithstereotacticablativeradiotherapy